Newsroom

NASHVILLE, Tenn.--(BUSINESS WIRE)--Cryomate Sperm Bank opens its second U.S. location in Nashville, expanding access to diverse sperm donors backed by advanced genetic screening....

LOS ANGELES--(BUSINESS WIRE)--Capstone Energy+, Inc. (NASDAQ: CEPL) (“Capstone” or the “Company”), a leading provider of behind-the-meter clean microturbine energy solutions for industrial and commercial businesses, as well as solutions designed for emerging data center applications, today announced that members of its management team are scheduled to participate in the LD Micro 20th Annual Main Event, which is being held from October 19-21, 2026 in Los Angeles, CA. Date: October 20, 2026 Locat...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

FRAMINGHAM, Mass. & ROSEBURG, Ore.--(BUSINESS WIRE)--Solar-plus-storage system offsets 100 percent of RUSA's Main Office electricity use and strengthens power reliability for wastewater operations....

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that its partner, Pierre Fabre Pharmaceuticals, Inc. (PFP), has received acceptance by the U.S. Food and Drug Administration (FDA) of the Biologics License Application (BLA) resubmission for tabelecleucel,...

SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies (NYSE: ST), today announced its brake force sensors are now enabling electromechanical braking (EMB) systems in leading electric vehicles. This milestone marks a significant step in the transition from traditional hydraulic braking to fully electric, brake-by-wire systems, as vehicle OEMs increasingly adopt architectures designed for electrification, autonomy, and software-defined control. Electromechanical brakes represent a shift...

BOSTON--(BUSINESS WIRE)--Delve Detect Plasma enables unbiased detection of more than 68,000 bacteria, fungi, DNA and RNA viruses, and parasites with next-day results...

DUBLIN--(BUSINESS WIRE)--B-Secur and Beacon Hospital Research Institute launch clinical pilot to bring ECG data from any consumer wearable directly into the clinical workflow....

BOSTON--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ: HYFT) (“MindWalk” or the “Company”), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company’s pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director, Antigen Discovery & Protein Engineering, from Arbor Biotechnologies and previously Pfizer. Joanne Lim, PhD, joins as Director, Preclinical Development, from Orum Ther...